Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment
Keywords: گلیسین; Latent inhibition; Amphetamine; NMDA antagonist; Antipsychotic drugs; Cognitive enhancers; Glycine; Physostigmine; Alpha7; Animal model; Schizophrenia